- 专利标题： TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS
-
申请号： US17412650申请日： 2021-08-26
-
公开(公告)号： US20220064165A1公开(公告)日： 2022-03-03
- 发明人: Kai Liu , Brent Douty , Daniel Levy , Liangxing Wu , Wenqing Yao , Eddy W. Yue
- 申请人： Incyte Corporation
- 申请人地址： US DE Wilmington
- 专利权人： Incyte Corporation
- 当前专利权人： Incyte Corporation
- 当前专利权人地址： US DE Wilmington
- 主分类号： C07D471/14
- IPC分类号： C07D471/14
摘要：
The present application provides tricyclic urea compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.
公开/授权文献
- US11661422B2 Tricyclic urea compounds as JAK2 V617F inhibitors 公开/授权日：2023-05-30
信息查询
